Search Press releases Keywords From To 25 Jun 2021 UCB Receives Positive CHMP Opinion Recommending Approval of BIMZELX[®*] (bimekizumab) in the EU for the Treatment of Adults with Moderate to Severe Plaque Psoriasis Read More 18 Jun 2021 Disposals of own shares Read More 11 Jun 2021 Disposals of own shares Read More 4 Jun 2021 Disposals of own shares Read More 1 Jun 2021 EULAR 2021: New Data from UCB’s Rheumatology Portfolio Demonstrates Real World Value for Patients with axSpA, PsA, and Women of Childbearing Age Read More 25 May 2021 Disposals of own shares Read More Pagination First page Previous page Previous … Page 44 Page 45 Page 46 Page 47 Current page 48 Page 49 Page 50 Page 51 Page 52 … Page 48 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe